Table 3

CRP level, VAS and BAS scores during the first (n=1436), second (n=432) and third treatment course (n=137)

Treatment courseTreatment durationpp
0 months3 months6 months0 vs 3  months0 vs 6  months
CRP (mg/l)
 113 (5.0–26)4.0 (1.0–9.0)4.0 (1.0–9.0)0.0010.001
 28.0 (2.0–20)5.0 (2.0–11)3.0 (1.0–7.0)0.090.001
 39.0 (3.0–21)4.0 (1.0–12)6.0 (2.0–11)0.20.1
VAS fatigue (mm)
 168 (50–81)33 (16–60)32 (12–61)0.0010.001
 268 (47–82)49 (17–74)41 (17–69)0.0010.001
 371 (60–82)61 (39–84)54 (31–78)0.020.04
VAS global (mm)
 168 (49–81)25 (11–51)24 (10–52)0.0010.001
 268 (45–81)38 (12–67)36 (15–65)0.0010.001
 371 (56–85)60 (46–76)57 (30–76)0.040.01
VAS pain (mm)
 165 (46–78)22 (9–48)20 (9–47)0.0010.001
 262 (40–78)36 (12–62)31 (11–56)0.0010.001
 366 (45–83)57 (40–74)48 (28–75)0.060.04
BASDAI (mm)
 159 (45–71)28 (11–48)28 (11–50)0.0010.001
 256 (38–73)36 (19–64)33 (16–59)0.0010.001
 364 (48–79)51 (36–67)52 (28–63)0.0020.001
BASFI (mm)
 150 (34–67)28 (11–48)28 (11–50)0.0010.001
 252 (35–70)36 (17–60)41 (17–58)0.0010.001
 364 (42–79)51 (30–73)52 (38–74)0.020.04
BASMI
 140 (20–60)20 (10–50)30 (10–50)0.0010.001
 230 (20–50)30 (10–40)30 (10–50)0.080.007
 340 (20–60)35 (20–50)40 (20–50)0.030.006
  • Results from Wilcoxon signed rank test. Values are medians and IQR.

  • Outcome data were reported according to the registrations in DANBIO at the following time-points: 0 months (upon initiation of therapy), 3 months (10–17 weeks), 6 months (18–32 weeks). If more registrations occurred within a given time interval, the one closest to the given time-point was selected. If a patient had no registrations within a given time interval, data were registered as missing for the given time-point.

  • BASDAI, Bath AS Disease Activity Index; BASFI, Bath AS Function Index; BASMI, Bath AS Metrology Index; CRP, C reactive protein; VAS, visual analogue scale.